Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201612045623N95
IRCT201612045623N95
Completed
Phase 3

Clinical trial of the effect of selenium supplementation compared with the placebo on gene expression involved in inflammation signaling pathway in patients with gestational diabetes

Vice chancellor for research, Arak University of Medical Sciences0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGestational diabetes.Diabetes mellitus in pregnancy, unspecifiedE28.2

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Gestational diabetes.
Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chancellor for research, Arak University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Patients with gestational diabetes
  • •aged 18 to 40 years

Exclusion Criteria

  • •Taking selenium supplements before the intervention
  • •Needing insulin therapy
  • •Placenta abruption
  • •Pre\-eclampsia
  • •Hypo and hyperthyroidism

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Effect of supplementation in treatment of women with polycystic ovary syndrome of IVF candidatePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
IRCT201704245623N113Vice chancellor for research, Shahid Beheshti University of Medical Sciences40
Completed
Phase 3
Effect of selenium supplementation in the treatment of women with polycystic ovary syndrome candidate for IVF.Polycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
IRCT20170513033941N23Shahid Beheshti University of Medical Sciences40
Completed
Phase 3
Effect of selenium supplementation in treatment of gestational diabetes mellitus
IRCT20170513033941N35Iran University of Medical Sciences40
Completed
Phase 3
Effect of supplementation in treatment of pregnant women at risk for intrauterine growth restrictioPregnancy.Sequelae of complication of pregnancy, childbirth and the puerperium
IRCT201601045623N64Vice chancellor for research, Kashan University of Medical Sciences60
Completed
Phase 3
Effect of supplementation in treatment of Congestive Heart Failure
IRCT2017053033941N2Vice chancellor for research, Kashan University of Medical Sciences60